Glendon Capital Management LP Bausch Health Companies Inc. Transaction History

Glendon Capital Management LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$27.43 - $32.7 $11 Million - $13.1 Million	-400,709 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$21.37 - $34.38 $1.15 Million - $1.85 Million	-53,801 Reduced 11.84%	400,709 $12.7 Million
Q4 2020 Feb 16, 2021	SELL	$15.31 - $21.12 $757,982 - $1.05 Million	-49,509 Reduced 9.82%	454,510 $9.45 Million
Q3 2020 Nov 10, 2020	SELL	$14.88 - $20.13 $277,154 - $374,941	-18,626 Reduced 3.56%	504,019 $7.83 Million
Q4 2019 Feb 14, 2020	BUY	$18.89 - $31.89 $2.27 Million - $3.83 Million	120,000 Added 29.8%	522,645 $15.6 Million
Q3 2019 Nov 14, 2019	BUY	$20.88 - $25.66 $6.21 Million - $7.64 Million	297,645 Added 283.47%	402,645 $8.8 Million
Q2 2019 Aug 14, 2019	BUY	$20.52 - $26.45 $2.15 Million - $2.78 Million	105,000 New	105,000 $2.65 Million

270

279M

5.68M

17.4M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $3.54B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Glendon Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Glendon Capital Management LP with notifications on news.